Posts Tagged 'pcsk9 inhibitors'

Review Group Says New Cholesterol Drugs Too Expensive

new drugs criticized for high pricesAccording to an NBC News report, the Institute for Clinical and Economic Review (ICER), an independent, non-profit organization that analyzes clinical and cost effectiveness in new medicines, has taken issue with the price of two recently approved cholesterol drugs. The medications, which belong to a new class of cholesterol drugs called proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, are Sanofi and Regeneron’s Praluent and Amgen’s Repatha. ...

continue reading...